The MIND Study - Microangiopathy IN Diabetes

NCT06989190 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2025-05-25

No results posted yet for this study

Summary

This clinical investigation will evaluate two contactless optical devices based on spatial frequency domain and laser speckle technology for quantification of the skin micro-circulation in patients with diabetes mellitus type 1.

Conditions

  • Diabetes Type 1

Sponsors & Collaborators

  • HJN Sverige AB/Neko Health

    lead INDUSTRY

Principal Investigators

  • Sarah Tehrani, MD, PhD · Danderyd Hospital, Department of Internal Medicine, Stockholm, Sweden

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-19
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06989190 on ClinicalTrials.gov